Establishment Labs® Reports Third Quarter 2026 Financial Results
Establishment Labs reported Q3 2026 revenue of $72.0 million, up 33.9% year-over-year, driven by 119% U.S. growth and a 124% increase in its minimally invasive platform. The company achieved its first-ever quarter of positive operating cash flow (~$7.7 million) and free cash flow ($5.1 million), with Adjusted EBITDA of $6.4 million, up from $1.2 million a year ago. Full-year 2026 revenue guidance was raised to more than $274 million from the prior $269-271 million range, and management expects 25% growth with positive cash flow in fiscal 2027.
Key figures
- Revenue
- 71993000
- Guidance
- FY26 revenue raised to more than $274 million from prior $269-271 million; adjusted gross margin ~70.7%; adjusted opex $195-200M; positive FY adjusted EBITDA; fiscal 2027 growth expected at 25% with positive cash flow
- Revenue Yoy
- 33.9%
- Fcf
- 5072000
- Cash
- $75.8 million
- Us revenue
- $26.0 million (+119.0% YoY)
- Ous revenue
- $46.0 million (+9.7% YoY)
- Us accounts
- more than 2,100
- Gaap net loss
- $10.7 million
- Adjusted ebitda
- 6384000
- Gaap gross margin
- 69.1%
- Operating cash flow
- $7.7 million
- Adjusted gross margin
- 70.8%
- Adjusted ebitda margin
- 8.9%
- Minimally invasive revenue
- approximately $9 million (+124.0% YoY)
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.